Epstein Secrets

st, 74 mg/dL). antibodies were reported to develop. Some Takeaways from FOURIER "We've never been able to plumb these depths before." lead author Marc S. Sabatine, MD, of Brigham and Women's Hospital and Harvard Medical School, said in a conference press release. "These data strongly suggest that patients ben

pproximately 50% higher than had been postulated led to a shorter required duration of follow-up to accrue the prespecified number of events." Dr. Sabatine emphasized the importance of aggressive LDL-lowering treatment in the future. "We need to treat LDL cholesterol more aggressively, and now we have a

t across quartiles of baseline LDL level (highest, 126 mg/dL to lowest, 74 mg/dL). 'We've never been able to plumb these depths before," lead author Marc S. Sabatine, MD, of Brigham and Women's Hospital and Harvard Medical School, said in a conference press release. "These data strongly suggest that patients ben

pproximately 50% higher than had been postulated led to a shorter required duration of follow-up to accrue the prespecified number of events." Dr. Sabatine emphasized the importance of aggressive LDL-lowering treatment in the future. "We need to treat LDL cholesterol more aggressively, and now we have a

ss quartiles of baseline LDL level (highest, 126 mg/dL to lowest, 74 mg/dL). IIr 'We've never been able to plumb these depths before," lead author Marc S. Sabatine, MD. of Brigham and Women's Hospital and Harvard Medical School, said in a conference press release. -These data strongly suggest that patients ben

approximately 50% higher than had been postulated led to a shorter required duration of follow-up to accrue the prespecified number of events' Dr. Sabatine emphasized the importance of aggressive LDL-lowering treatment in the future. "We need to treat LDL cholesterol more aggressively, and now we have a